Sepsis Clinical Trial
Official title:
Evaluation of a on Community-Based Management of Neonatal Sepsis
More than half of under-five deaths in Bangladesh occur in the first month of life (neonatal
period), and a substantial proportion of these deaths are due to infections (sepsis).
According to the recently formulated Bangladesh National Neonatal Health Strategy (NNHS),
the Government of Bangladesh is committed to improve access to quality management of
neonatal infections. The strategy emphasizes that health service providers at all levels
acquire the skills for managing sepsis.
Responding to the recommendations in the National Neonatal Health Strategy, this operations
research seeks to evaluate alternative approaches for the management of neonatal sepsis in
the community. The evaluation will focus on assessing intervention coverage, provider
quality of care, and referral and referral compliance, and will undertake cost-benefit
analysis of community-based neonatal sepsis management. The programme and evaluation will be
within the existing health service delivery system in Bangladesh and is thus designed to
inform the effective scaling up of neonatal sepsis management and contribute to the
implementation of the NNHS. The interventions to be evaluated will be nested in the
Maternal, Neonatal and Child Survival (MNCS) programme being implemented by the Government
of Bangladesh, in partnership with and supported by UNICEF, and several national NGOs.
This operations research is being implemented by the Government of Bangladesh in
collaboration with UNICEF, SNL - Save the Children (USA), Bangladesh Perinatal Society, and
ICDDR,B. It will take place in four MNCS programme upazilas, where 10 unions will be
randomly selected for intervention and 10 unions will be comparison. The intervention
consists of training of community health workers, village doctors and health facility
workers on managing neonatal sepsis in addition to essential newborn care training. In the
comparison areas the health workers will only receive essential newborn care training.
The intervention and evaluation will continue for at least 18 months, with rolling surveys
and two special surveys at 6 and 12 months into the project. The rolling surveys will look
at intervention coverage, care-seeking, and referral and referral compliance, while the two
special surveys will assess provider performance, referral compliance, and quality of care.
In addition, the investigators will document implementation processes to understand what
worked and what did not and why.
Three to four MNCS programme upazilas will be purposively selected for this study in
consultation with GoB and partners. The likely districts from where the three to four
upazilas will be selected include Sunamganj, Kishoreganj, Bandarban and Sherpur. However,
this may change depending on GoB/UNICEF decisions about MNCS scale-up. The upazilas will be
selected considering presence of NGO partners with the ability to implement the
intervention, start of MNCS in the upazilas by 2009 and no overlap with other similar
programmes research projects. Twenty unions (average population of about 20,000) will be
identified from the selected upazilas and randomly assigned to intervention or comparison.
Unions with substantial urban populations will be excluded. In order to achieve balance in
randomisation across upazilas, the investigators will make efforts to select an even number
of unions from the selected upazilas.
Study design
A cluster-randomised design will be used. Of the 20 selected unions in the selected
sub-districts/upazilas, 10 will be randomly assigned to intervention and 10 to comparison,
that is, about 200,000 population (~40,000 households) in each arm. In both intervention and
comparison unions, the common MNCS intervention package will be uniformly implemented, which
includes training of community-based health workers on essential newborn care. Details of
the MNCS intervention package and delivery systems can be found in Annex I. All the MNCS
upazilas have also already implemented facility-based IMCI.
The objective of randomisation is to ensure balance between intervention and comparison
areas in terms of population and geographical characteristics and coverage of health
interventions and programmes. The sampling units (unions) will be stratified according to
upazila. If any union has a total population of less then 12,000 (the minimum required to
obtain an adequate sample of neonates) they will either be excluded or if such exclusion
results in fewer than 20 unions being available for randomisation then two such small unions
will be merged and considered as a single sampling unit. Equal number of unions for
intervention or comparison will be selected from each upazila. Within each upazila, unions
will be paired on distance from the upazila health complex and members of each pair be
randomly selected for intervention or comparison.
In the intervention unions, in addition to routine MNCS services, services for the
management of neonatal sepsis will be made available in the community, targeting all
pregnant women and newborns born within the study period. Community-based management of
neonatal sepsis will be provided by three types of care providers: community health workers,
village doctors and community clinic care providers.
The intervention and evaluation will continue for at least 18 months. Evaluation will be
ongoing and include rolling household surveys to assess intervention coverage and
care-seeking and referral compliance practices. In addition, two special surveys will be
conducted to assess provider performance, referral compliance, quality of care at the
different levels of care, and incremental program and household costs. The first special
survey will be conducted at 6 months after the implementation of the intervention and then
again at 12 months. The first round of rolling survey will also include a sample of newborns
born in the previous 12 months to assess baseline care-seeking patterns and coverage for
neonatal sepsis.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05095324 -
The Biomarker Prediction Model of Septic Risk in Infected Patients
|
||
Completed |
NCT02714595 -
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
|
Phase 3 | |
Completed |
NCT03644030 -
Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
|
||
Completed |
NCT02867267 -
The Efficacy and Safety of Ta1 for Sepsis
|
Phase 3 | |
Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
Recruiting |
NCT05578196 -
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
|
N/A | |
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Completed |
NCT03550794 -
Thiamine as a Renal Protective Agent in Septic Shock
|
Phase 2 | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Completed |
NCT03258684 -
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Completed |
NCT05018546 -
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
|
N/A | |
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 |